Ceredase Related Clinical Trials
Safety and Efficacy of CerezymeŽ Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease [Completed]
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase [Recruiting]
Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase [Recruiting]
A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. [Completed]
Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease [Available]
Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease [Available]
Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD) [Completed]
The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease [Not yet recruiting]
Effects of Enzyme Replacement in Gaucher's Disease [Completed]
A Study of GA-GCB Enzyme Replacement Therapy in Gaucher Disease [Active, not recruiting]
PEG-Glucocerebrosidase for the Treatment of Gaucher Disease [Completed]
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease [Recruiting]
Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients [Not yet recruiting]
Bone Response to Enzyme Replacement in Gaucher's Disease [Completed]
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease [Completed]
A Study of the Efficacy and Safety of Genz-112638 in Type 1 Gaucher Patients [Active, not recruiting]
Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations [Recruiting]
Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease [Recruiting]
A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease [Recruiting]
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE) [Recruiting]
Thrombocytopathy in Gaucher Disease Patients [Recruiting]
International Collaborative Gaucher Group (ICGG) Gaucher Registry [Recruiting]
Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease [Completed]
Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells [Completed]
Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease [Recruiting]
Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT) [Active, not recruiting]
Safety Study of AT2101 in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy [Completed]
Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation [Recruiting]
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease [Completed]
A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease [Recruiting]
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) [Recruiting]
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease(ENGAGE) [Recruiting]
Biomarker for Gaucher Disease [Recruiting]
Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells in Gaucher Disease [Recruiting]
A Screening Study Evaluating Disease Status of Gaucher Type I Patients [Recruiting]
Exploration of Immunity in Gaucher Disease [Recruiting]
A Long-Term Extension Study of AT2101 in Type 1 Gaucher Patients [Not yet recruiting]
A Study of AT2101 in Patients With Gaucher Disease
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease [Completed]
|
